H1N1 deaths increase as mutations combine – vaccine & antiviral resistant, lung hemorrhaging virus

by Rob Daven on November 28, 2009

in Pale Horse News

The World Health Organization has reported that global deaths from the H1N1 virus have increased by 1000 in the past week. At the same time, the H1N1 virus is mutating, with each mutation causing different effects in patients, and combining in some cases.

The national medical laboratory in Britain reported that the H1N1 vaccine would probably not be effective against the variant of the swine flu virus found in the Ukraine flu outbreak.

This variant, in which the virus uses D225G as a receptor binding domain, causes bleeding in the lungs. Another H1N1 mutation results in the resistance to treatment with antiviral medication.

Swine flu vaccine won’t prevent infection with deadly H1N1 mutated virusThe same mutation that results in acute respiratory damage, due to the location of the viral infection, has been called a “low reactor” to the vaccine.

This means that the vaccine will not provide an immune response for that strain of virus adequate to prevent infection.

via H1N1 deaths increase as mutations combine – vaccine & antiviral resistant, lung hemorrhaging virus.

Post comment as twitter logo facebook logo
Sort: Newest | Oldest

Previous post:

Next post: